Biocryst Pharmaceuticals Inc.

NASDAQ: BCRX
Share price (4/24/24): $4.21
Market cap (4/24/24): $868 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

8 Biocryst Pharmaceuticals Inc. Expert Interviews, now on BamSEC.

Powered by Tegus.

Financials Filter

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

ended 12/31/22 FY 2022

Prospectuses and Registrations Filter

Automatic shelf registration

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Thackray Helen M.

Baker Bros. Advisors LP

Avoro Capital Advisors LLC

News Filter

Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Announces Preliminary Full Year 2023 ORLADEYO® (Berotralstat) Net Revenue of $325 Million, Provides 2024 Guidance and Accelerated Path to Profitability

Change in Directors, Officers or Compensation

Material Disclosure

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

SEC STAFF LETTER